Benefits of AstraZeneca vaccine continue to outweigh the risks, says EMA
European Medicines Agency (EMA) said on Tuesday the benefits of AstraZeneca’s COVID-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots.
EMA Executive Director Emer Cooke said there was no indication that the blood clot incidents, which he called “very rare” had been caused by the vaccine, but that experts were assessing that possibility.
Trust in the safety of the vaccines was paramount and the agency was carrying out a case-by-case evaluation, he said.
“The benefits continue to outweigh the risks, but this is a serious concern and it does need serious and detailed scientific evaluation. This is what we are involved in at the moment,” Cooke told a news conference.
The results of its findings would be discussed during an EMA review on Thursday after which the results would be made public, Cooke said.
Sweden and Latvia on Tuesday suspended use of the vaccine, bringing to more than a dozen the number of EU countries to act since reports first emerged of thromboembolisms affecting people after they got the AstraZeneca shot.
As we wrote today, answering a question about the suspension of AstraZeneca’s vaccine in several countries, Foreign minister Szijjártó said today:
Hungary was also monitoring the effect of the vaccine, and its experts would decide on any further steps to be taken.
Source: Reuters
Politized propaganda by European Union member countries.
17 million human beings vaccinated prior to this “excuse”.
Factual reports state there is 8 million plus dosages of this vaccine that has been distributed to member countries of the European Union, that have not been used.
Stockpiling through organizational incompetency and planning.
The mounting level of this vaccine by certain European countries that have dismally failed to get there acts together to immunize there people, are attempting to build a case, giving them a position of shifting blame onto AstraZeneca.
Statistical Medical evidence highlights that the positives of this vaccine in it’s use outweighs the negative unsound without proven statistical medical data for it’s use in the immunization of human beings in our fight against this novel coronavirus.